Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
45

Summary

Conditions
  • Breast Cancer
  • Colorectal Carcinoma
  • Melanoma
  • Non Small Cell Lung Carcinoma
  • Ovarian Cancer
  • Pancreatic Carcinoma
  • Prostate Cancer
  • Renal Cell Carcinoma
  • Solid Tumors
Type
Interventional
Phase
Phase 1
Design
Allocation: Non-RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT02009449
Collaborators
ARMO BioSciences
Investigators
Study Director: Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) Eli Lilly and Company